MEDP240816C400000
- 23.20
- 0.000.00%
Medpace Newsroom
Notable Earnings After Monday's Close
Backlog Conversion Likely to Aid Medpace's (MEDP) Q2 Earnings
Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?
Medpace (MEDP) Beats Stock Market Upswing: What Investors Need to Know
In the latest market close, Medpace (MEDP) reached $443, with a +1.84% movement compared to the previous day.
Baird Adjusts Medpace Holdings' Price Target to $469 From $456, Keeps Outperform Rating
Medpace Holdings (MEDP) has an average rating of outperform and price targets ranging from $296 to $480, according to analysts polled by Capital IQ.Price: 402.80, Change: +0.40, Percent Change: +0.10
Medpace Holdings Is Maintained at Outperform by Baird
Medpace Holdings Is Maintained at Outperform by Baird
Baird Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $469
Baird analyst Eric Coldwell maintains $Medpace(MEDP.US)$ with a buy rating, and adjusts the target price from $454 to $469.According to TipRanks data, the analyst has a success rate of 52.2% and a
Medpace Holdings, Inc.'s (NASDAQ:MEDP) P/E Still Appears To Be Reasonable
Medpace Holdings, Inc.'s (NASDAQ:MEDP) price-to-earnings (or "P/E") ratio of 39.8x might make it look like a strong sell right now compared to the market in the United States, where around half of the
$1000 Invested In Medpace Hldgs 5 Years Ago Would Be Worth This Much Today
Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 31.94% on an annualized basis producing an average annual return of 45.04%. Currently, Medpace Hldgs has a market capit
Peering Into Medpace Hldgs's Recent Short Interest
Medpace Hldgs's (NYSE:MEDP) short percent of float has fallen 8.61% since its last report. The company recently reported that it has 854 thousand shares sold short, which is 4.14% of all regular share
Medpace Holdings, Inc. to Report Second Quarter 2024 Financial Results on July 22, 2024
CINCINNATI--(BUSINESS WIRE)--Jun. 26, 2024-- Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its second quarter 2024 financial results after the market close on M
An Intrinsic Calculation For Medpace Holdings, Inc. (NASDAQ:MEDP) Suggests It's 28% Undervalued
In this article we are going to estimate the intrinsic value of Medpace Holdings, Inc. (NASDAQ:MEDP) by taking the expected future cash flows and discounting them to their present value.
Here's How Much You Would Have Made Owning Medpace Hldgs Stock In The Last 5 Years
Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 32.97% on an annualized basis producing an average annual return of 46.08%. Currently, Medpace Hldgs has a market capit
Express News | Medpace Holdings Inc : Baird Raises Target Price to $456 From $454
Medpace Holdings (MEDP) Continues to Deliver Robust Financial Results
How Is The Market Feeling About Medpace Hldgs?
Medpace Hldgs's (NYSE:MEDP) short percent of float has fallen 4.16% since its last report. The company recently reported that it has 902 thousand shares sold short, which is 4.38% of all regular share
Medpace(MEDP.US) Officer Sells US$3.08 Million in Common Stock
$Medpace(MEDP.US)$ Officer BURWIG SUSAN E sold 7,681 shares of common stock on Jun 5, 2024 at an average price of $401.2 for a total value of $3.08 million.Source: Announcement What is statement of ch
Medpace Holdings Insider Sold Shares Worth $3,081,617, According to a Recent SEC Filing
Susan E Burwig, Executive Vice President, Operations, on June 05, 2024, sold 7,681 shares in Medpace Holdings (MEDP) for $3,081,617. Following the Form 4 filing with the SEC, Burwig has control over a
We Ran A Stock Scan For Earnings Growth And Medpace Holdings (NASDAQ:MEDP) Passed With Ease
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Unfortunately, these high risk investment
If You Invested $100 In This Stock 5 Years Ago, You Would Have $700 Today
Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 36.06% on an annualized basis producing an average annual return of 49.13%. Currently, Medpace Hldgs has a market capit